-
Product Insights
Azure Offshore Wind Project, Australia
Azure Offshore Wind Project is proposed to be developed in Indian Ocean, Australia. Empower your strategies with our Azure Offshore Wind Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a...
-
Product Insights
Seizures – Drugs In Development, 2023
Global Markets Direct’s, ‘Seizures - Drugs In Development, 2023’, provides an overview of the Seizures pipeline landscape. The report provides comprehensive information on the therapeutics under development for Seizures, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Childhood Epilepsy – Drugs In Development, 2023
Global Markets Direct’s, ‘Childhood Epilepsy - Drugs In Development, 2023’, provides an overview of the Childhood Epilepsy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Childhood Epilepsy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Endocrine Gland Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Endocrine Gland Disorders - Drugs In Development, 2023’, provides an overview of the Endocrine Gland Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Endocrine Gland Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Generalized Seizures – Drugs In Development, 2023
Global Markets Direct’s, ‘Generalized Seizures - Drugs In Development, 2023’, provides an overview of the Generalized Seizures pipeline landscape. The report provides comprehensive information on the therapeutics under development for Generalized Seizures, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) – Drugs In Development, 2023
Global Markets Direct’s, ‘Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) - Drugs In Development, 2023’, provides an overview of the Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Tonic-Clonic (Grand Mal) Seizure – Drugs In Development, 2023
Global Markets Direct’s, ‘Tonic-Clonic (Grand Mal) Seizure - Drugs In Development, 2023’, provides an overview of the Tonic-Clonic (Grand Mal) Seizure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tonic-Clonic (Grand Mal) Seizure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Partial Seizure – Drugs In Development, 2023
Global Markets Direct’s, ‘Partial Seizure - Drugs In Development, 2023’, provides an overview of the Partial Seizure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Partial Seizure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Lennox-Gastaut Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Lennox-Gastaut Syndrome - Drugs In Development, 2023’, provides an overview of the Lennox-Gastaut Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lennox-Gastaut Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Analyst Opinions
Sustainable Aviation Fuel – The Way Forward for Aviation Industry
Sustainable Aviation Fuel Report Overview There are currently 9 pathways for producing sustainable aviation fuel (SAFs), which are certified by the IATA. However, hydrotreatment remains the dominant pathway for the bulk of current SAF production. As SAF production increases, alternative pathways will become more prominent such as alcohol-to-jet (ATJ) and power-to-liquid (PtL) technologies. The sustainable aviation fuel research report provides an assessment of the global commercial aviation sector’s decarbonization challenge. The report also covers the potential role of sustainable aviation...